Are you an India-based academic, R&D manager or scientist interested in transitioning your #AMR #bacterial #diagnostic into an IVD product?

🖥️ Register for the 5-part seminar series from November 7 through December 9.

Topics include:

*️ (11 Nov.) Product development process

*️ (18 Nov.) Design controls

*️ (21 Nov.) Real-life stories: Academia to commercialization

*️ (2 Dec.) Quality management and good laboratory practices

*️ (9 Dec.) Case study: Why the fundamentals matter

Q&A Panelists:

*️ Taslimarif Saiyed, Director and CEO, C-CAMP
*️ Rangarajan Sampath, Senior Vice President and Head, Center for Innovation in Diagnostics, Siemens Healthineers
*️ Tara deBoer, Chief Executive Officer, BioAmp Diagnostics
*️ Debkishore Mitra, Chief Technology Officer and co-founder, Lucira Health
*️ Chandrasekhar Nair, Director, Molbio Diagnostics
*️ Peter J. Dailey, Senior Technical Officer, FIND

Moderated by Betsy Wonderly Trainor, Diagnostics Alliance Director, CARB-X

47% of the global population does not have access to basic diagnostics. To increase access where the global AMR burden is most acute (see fig. 2), CARB-X is partnering with FIND and C-CAMP to support the diagnostic product development ecosystem in India.